Skip to news
JQJO
Latest

Pfizer files second suit over Metsera bid | JQJO

Pfizer files second suit over Metsera bid

Pfizer files second suit over Metsera bid

Tap title to read story

0:00 / 0:39

Pfizer filed a second lawsuit against Novo Nordisk and Metsera, accusing the Ozempic maker of an anticompetitive bid to acquire the obesity biotech and cement dominance in a booming market. The Delaware federal suit also claims Metsera’s controlling shareholders conspired with Novo. Novo’s spokesperson called Pfizer’s allegations baseless, saying its offer follows the law and serves patients and Metsera shareholders. Metsera said Pfizer is trying to litigate its way to a cheaper price. The case follows Pfizer’s Friday suit to preserve its own merger agreement and challenge Novo’s $6 billion offer.

Published · Published by JQJO

Published by JQJO Editorial Desk · AI assisted

More context

Sources

JQJO Editorial Desk · Human reviewed · AI assisted. Report a correction.

Editorial policy and corrections · Our team

Chalamet Declines Call Me By Your

Tap title to read story

0:00 / 0:00

JQJO

Find your next story

Search JQJO’s current coverage.